Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Equal-Weight on Definitive Healthcare, Raises Price Target to $11

Author: Benzinga Newsdesk | March 01, 2024 07:09am
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and raises the price target from $10 to $11.

Posted In: DH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist